Relationship of metabolic risk factors and development of cardiovascular disease and diabetes
- PMID: 16931493
- DOI: 10.1038/oby.2006.291
Relationship of metabolic risk factors and development of cardiovascular disease and diabetes
Abstract
The prevalence of obesity and diabetes has reached pandemic proportions. Obesity, particularly in association with high waist circumference and high BMI, is an independent risk factor for coronary heart disease (CHD) and diabetes. Several large studies have shown that marginal (5 lb) to moderate (11 to 22 lb) weight gain in adulthood (age 20 to 50 years) increases the risk of chronic disease and negatively affects CHD risk status. The metabolic syndrome, a clustering of cardiovascular and metabolic risk factors that includes abdominal obesity, is increasing among adults and children and is strongly associated with the development of diabetes and CHD. Recent evidence suggests that elevated liver enzymes, an indicator of non-alcoholic fatty liver disease, may comprise an additional component of the metabolic syndrome and may serve as a surrogate marker for type 2 diabetes, particularly if used in conjunction with C-reactive protein.
Similar articles
-
Abdominal obesity, waist circumference and cardio-metabolic risk: awareness among primary care physicians, the general population and patients at risk--the Shape of the Nations survey.Curr Med Res Opin. 2007 Jan;23(1):29-47. doi: 10.1185/030079906X159489. Curr Med Res Opin. 2007. PMID: 17261236
-
What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?J Gastroenterol Hepatol. 2007 Jun;22(6):794-800. doi: 10.1111/j.1440-1746.2007.04952.x. Epub 2007 May 13. J Gastroenterol Hepatol. 2007. PMID: 17498218
-
Type 2 diabetes mellitus: a high-risk condition for cardiovascular disease irrespective of the different degrees of obesity.QJM. 2008 Nov;101(11):875-9. doi: 10.1093/qjmed/hcn109. Epub 2008 Sep 6. QJM. 2008. PMID: 18776208
-
The cardiometabolic syndrome in the adolescent.Pediatr Endocrinol Rev. 2008 Aug;5 Suppl 4:964-8. Pediatr Endocrinol Rev. 2008. PMID: 18806711 Review.
-
Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?Crit Pathw Cardiol. 2007 Jun;6(2):41-5. doi: 10.1097/HPC.0b013e318053d190. Crit Pathw Cardiol. 2007. PMID: 17667863 Review.
Cited by
-
Does Moringa oleifera Lam. leaves supplementation have an impact on the weight and bone mass index of people living with HIV that are on antiretroviral therapy? A double-blind randomized control trial.J Public Health Afr. 2022 Sep 29;13(3):2126. doi: 10.4081/jphia.2022.2126. eCollection 2022 Sep 7. J Public Health Afr. 2022. PMID: 36277954 Free PMC article.
-
On age-specific variations in income-related inequalities in diabetes, hypertension and obesity.Int J Public Health. 2013 Feb;58(1):33-41. doi: 10.1007/s00038-012-0368-7. Epub 2012 May 9. Int J Public Health. 2013. PMID: 22569915
-
Obesity prevalence and unfavorable health risk behaviors among German kindergarten teachers: cross-sectional results of the kindergarten teacher health study.BMC Public Health. 2013 Oct 4;13:927. doi: 10.1186/1471-2458-13-927. BMC Public Health. 2013. PMID: 24093334 Free PMC article.
-
Quantification of lipid droplets and associated proteins in cellular models of obesity via high-content/high-throughput microscopy and automated image analysis.Assay Drug Dev Technol. 2009 Oct;7(5):440-60. doi: 10.1089/adt.2009.0196. Assay Drug Dev Technol. 2009. PMID: 19895345 Free PMC article.
-
To Investigate the Effect of Dyslipidemia and Metabolic Function in Coronary Heart Disease with Type 2 Diabetes Mellitus-In the Tertiary Care Center. A Study Protocol.J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S919-S920. doi: 10.4103/jpbs.jpbs_1963_24. Epub 2025 Mar 6. J Pharm Bioallied Sci. 2025. PMID: 40511010 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials